Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature review

Two‐sided influence of dupilumab on alopecia areata co‐existing with severe atopic dermatitis: A case series and literature review

Abstract Objectives Alopecia areata (AA) often coexists with atopic dermatitis (AD). Recently, several reports suggested that dupilumab, an interleukin 4 receptor α‐antagonist, administration could be a promising medication not only for severe AD but also for AA concomitant with AD (AD‐AA). At the s...

Full description

Bibliographic Details
Main Authors: Masahiro Fukuyama, Misaki Kinoshita‐Ise, Yoshiko Mizukawa, Manabu Ohyama
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Journal of Cutaneous Immunology and Allergy
Subjects:
alopecia areata
atopic dermatitis
Dupilumab
eczema area and severity index
thymus and activation‐regulated chemokine
Online Access:https://doi.org/10.1002/cia2.12289

Internet

https://doi.org/10.1002/cia2.12289

Similar Items